Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$42.05 - $47.77 $28,425 - $32,292
-676 Reduced 2.14%
30,869 $1.34 Million
Q1 2022

May 12, 2022

BUY
$40.23 - $47.74 $29,569 - $35,088
735 Added 2.39%
31,545 $1.37 Million
Q4 2021

Feb 15, 2022

BUY
$38.88 - $45.31 $218,311 - $254,415
5,615 Added 22.29%
30,810 $1.36 Million
Q3 2021

Nov 15, 2021

BUY
$38.79 - $43.16 $393,912 - $438,289
10,155 Added 67.52%
25,195 $963,000
Q2 2021

Aug 13, 2021

SELL
$36.52 - $41.46 $67,562 - $76,701
-1,850 Reduced 10.95%
15,040 $599,000
Q1 2021

May 13, 2021

SELL
$34.27 - $40.01 $86,154 - $100,585
-2,514 Reduced 12.96%
16,890 $603,000
Q4 2020

Feb 12, 2021

SELL
$34.07 - $39.94 $741,840 - $869,653
-21,774 Reduced 52.88%
19,404 $714,000
Q3 2020

Nov 13, 2020

BUY
$38.11 - $42.99 $392,304 - $442,539
10,294 Added 33.33%
41,178 $1.55 Million
Q2 2020

Jul 30, 2020

BUY
$37.87 - $43.58 $113,041 - $130,086
2,985 Added 10.7%
30,884 $1.26 Million
Q1 2020

May 18, 2020

BUY
$32.47 - $48.83 $73,025 - $109,818
2,249 Added 8.77%
27,899 $1.06 Million
Q4 2019

Feb 20, 2020

BUY
$42.0 - $48.25 $613,494 - $704,787
14,607 Added 132.27%
25,650 $1.21 Million
Q3 2019

Nov 15, 2019

BUY
$40.46 - $43.52 $218,848 - $235,399
5,409 Added 96.01%
11,043 $471,000
Q2 2019

Aug 15, 2019

SELL
$39.4 - $42.7 $37,508 - $40,650
-952 Reduced 14.45%
5,634 $225,000
Q1 2019

May 15, 2019

BUY
$38.57 - $42.69 $254,022 - $281,156
6,586 New
6,586 $275,000
Q3 2018

Nov 13, 2018

SELL
$39.75 - $42.69 $208,767 - $224,207
-5,252 Closed
0 $0
Q2 2018

Jul 27, 2018

SELL
$39.61 - $42.76 $1,386 - $1,496
-35 Reduced 0.66%
5,252 $211,000
Q1 2018

May 15, 2018

SELL
$36.18 - $40.15 $45,912 - $50,950
-1,269 Reduced 19.36%
5,287 $205,000
Q4 2017

May 15, 2018

BUY
$35.34 - $41.9 $231,689 - $274,696
6,556
6,556 $245,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.4B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.